Clinical trialNCT03000101CompletedInterventional

Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease

SponsorIRCCS Azienda Ospedaliero-Universitaria di BolognaEnrollment18Crohn's DiseaseUlcerative Colitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this research is to study the effects of a pomegranate juice on calprotectin levels in patients suffering of inflammatory bowel disease (IBD) in clinical remission. Fecal calprotectin levels, surrogate marker of mucosal inflammation, will be measured from baseline to 12 weeks later (end of intervention). Systemic and mucosal changes of biochemical and molecular inflammatory response markers will be also assessed.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Francesca Danesi, PhD
Department of Agri-Food Sciences and Technologies, University of Bologna
Study Director
clinicaltrials.gov ↗
Luigi Ricciardiello, MD, Prof
Department of Medical and Surgical Sciences, University of Bologna
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy

U.O. Gastroenterologia - Azienda Ospedaliero-Universitaria Di Bologna, Policlinico Sant'Orsola-Malpighi
Bologna, Italy

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jan 2017
Primary completion: 19 Jul 2023
Completion: 29 Dec 2023
Last update posted: 31 Jul 2026
Registered enrollment: 18
Registry id: NCT03000101

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.